RECURRENT ACUTE BIPHENOTYPIC LEUKEMIA
Clinical trials for RECURRENT ACUTE BIPHENOTYPIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ACUTE BIPHENOTYPIC LEUKEMIA trials appear
Sign up with your email to follow new studies for RECURRENT ACUTE BIPHENOTYPIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo aims to tame aggressive blood cancers
Disease control TerminatedThis study tested whether combining two drugs, omacetaxine and venetoclax, could help control acute myeloid leukemia or myelodysplastic syndrome that had returned or stopped responding to other treatments in patients with a specific genetic change called RUNX1. The goal was to fi…
Matched conditions: RECURRENT ACUTE BIPHENOTYPIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New drug combo tested for tough blood cancers in older adults
Disease control TerminatedThis study tested how well two chemotherapy drugs, venetoclax and decitabine, work together to control aggressive blood cancers. It was for older adults newly diagnosed with acute myeloid leukemia (AML) or people whose AML or high-risk myelodysplastic syndrome (MDS) had returned …
Matched conditions: RECURRENT ACUTE BIPHENOTYPIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC